Epicutis clinical study shows 77% improvement in skin appearance
Epicutis has launched Hydrobiome Serum, a professional skincare treatment featuring a patented TCP molecule. A recent double-blind, placebo-controlled s…
Longevity science decoded daily
Curated coverage of healthspan research, longevity therapeutics, and the science of living longer — tracked through the signals that matter.
1050
Articles
11
Signals
5
Topics
April 17, 2026
XellSmart launches multicenter Phase II trial of iPSC therapy
XellSmart has initiated a multicenter Phase II registrational clinical trial for XS411, an allogeneic, off-the-shelf **iPSC-derived dopam...
Read more →GNC adds MitoQ Pure and MitoQ NAD to The Drop
GNC has introduced MitoQ Pure and MitoQ NAD+ Dual Action in its innovation hub, The Drop by GNC, emphasizing targeted mitochondrial suppo...
Read more →Life Time rolls out SpiroFit metabolic testing to country clubs
Life Time is expanding its metabolic testing capabilities by introducing the SpiroFit system across its 190 athletic clubs in the U.S. an...
Read more →Scientists discover natural hormone that reverses obesity
Researchers at the University of Oklahoma have identified FGF21 (fibroblast growth factor 21) as a natural hormone capable of reversing o...
Read more →Scientists supercharge immune cells to destroy cancer more effectively
Researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy in Brazil have developed a novel approach to enhance...
Read more →A “death” protein may be the key to slowing aging at its source
Researchers at The University of Tokyo and St. Jude Children’s Research Hospital have identified a previously unrecognized role for the *...
Read more →April 16, 2026
Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto
Picard Medical, Inc. is set to showcase its advancements in mechanical circulatory support at the ISHLT 2026 Annual Meeting in Toronto, w...
Read more →New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026
StarkAge Therapeutics has announced the upcoming presentation of preclinical data on STX-1, a first-in-class senolytic antibody-drug conj...
Read more →Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse
Indivior PLC has released findings from a national survey published in the Journal of Correctional Health Care, revealing that correction...
Read more →In Search of Novel Means to Provoke Mild Mitochondrial Stress to Slow Aging
Researchers have identified terbinafine and miglustat as novel pharmacological inducers of the mitochondrial stress response (MSR), which...
Read more →New National Platform Launches to Bridge the Gap in Bereavement Care: Introducing GriefSupportDirectory.com
My Grief Angels Inc. has launched GriefSupportDirectory.com, a comprehensive platform that aggregates over 20,000 grief support resources...
Read more →p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease
**p21⁺Trem2⁺ senescent macrophages have been identified as a significant source of chronic inflammation, or inflammaging, in aging and me...
Read more →Air Europa Enhances Safety on Board by Incorporating Specialized Medical Assistance During Flights
Air Europa has partnered with MedAire to enhance in-flight medical assistance across its fleet, marking a significant advancement in pass...
Read more →AIRNA doses first patient in RNA-editing trial
AIRNA has initiated a Phase 1 clinical trial for AIR-001, a novel RNA editing therapy aimed at addressing Alpha-1 Antitrypsin Deficiency ...
Read more →SIRIO Europe rolls out new habit-first longevity platform
SIRIO Europe has launched Aeion, a groundbreaking “habit-first” longevity platform at Vitafoods Europe 2026, designed to transform comple...
Read more →Targeting an Appetite Hormone Receptor for Stronger Muscles
Researchers have identified a promising approach to combat sarcopenia in aging mice by targeting the ghrelin receptor (GHSR-1a) rather th...
Read more →Your immune system now has a digital twin for longevity
AYUN and Omniscope have launched a groundbreaking partnership in Zurich, introducing predictive immune modeling through the innovative “c...
Read more →The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
The U.S. cardiovascular devices market is poised for significant growth, projected to nearly double from $22.08 billion in 2025 to $41.29...
Read more →Baylor Genetics to Showcase the Impact of Early Genome Sequencing at Annual PLUGS Summit
Baylor Genetics is set to present at the upcoming Patient-centered Laboratory Utilization Guidance Services (PLUGS) Summit in Seattle, hi...
Read more →Hearing Aids Market Set to Reach $14.42 Billion by 2030 | MarketsandMarkets™
The global hearing aids market is poised for significant growth, projected to expand from USD 10.35 billion in 2025 to USD 14.42 billion ...
Read more →American Urological Association Releases Clinically Localized Prostate Cancer Guideline Amendment
The 2026 amendment to the Clinically Localized Prostate Cancer Guideline was released by the American Urological Association (AUA) in col...
Read more →Disability Insurance Resource for Medical Residents Launches After Record 2026 Match
The 2026 Main Residency Match has achieved a historic milestone, with 44,344 training positions offered across over 6,800 program tracks,...
Read more →AI can now understand health signals from 15 seconds of your voice, including type 2 diabetes, fatigue and stress
**Speechmatics and thymia have announced a groundbreaking collaboration to integrate medical-grade speech-to-text technology with clinica...
Read more →Parkinson’s drug cuts OFF time in Phase 2
Cerevance’s investigational drug solengepras is demonstrating promising results in alleviating motor “OFF” periods and sleep disturbances...
Read more →Mapi Pharma to Present Efficacy (EDSS) Data from Glatiramer Acetate Depot Long-Acting Injection Studies in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) at AAN 2026
Mapi Pharma Ltd. is poised to present promising efficacy data for its Glatiramer Acetate Depot (GA Depot) at the upcoming American Academ...
Read more →Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan
Progyny, Inc. has launched Progyny Select, a groundbreaking fully insured supplemental fertility and family building plan tailored for sm...
Read more →Retailers Nationwide Partner with Muscular Dystrophy Association to Send Hundreds of Young People to Life-Changing Summer Camp
The Muscular Dystrophy Association (MDA) is launching its annual Summer Retail Campaign, partnering with over 1,000 retail locations acro...
Read more →Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications
Royal Philips has secured FDA 510(k) clearance for its Spectral CT Verida system, a significant advancement in imaging technology that in...
Read more →Nearly 4 in 10 women are missing vaginal bacteria linked to fertility
Analysis by Tiny Health reveals that 39% of women sampled exhibited low or absent levels of Lactobacillus, a key bacterium in the vaginal...
Read more →Scientists remove “zombie” cells and reverse liver damage in mice
UCLA researchers have identified a population of senescent macrophages, termed “zombie” cells, that accumulate in aging tissues and contr...
Read more →ACHIEVE-4, the longest Phase 3 study of Lilly's Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
Lilly’s ACHIEVE-4 trial has yielded promising results for Foundayo (orforglipron), a novel oral glucagon-like peptide-1 receptor agonist....
Read more →IGF-1 Signaling Suppression Fails to Slow Aging in Mitochondrial Mutator Mice
Reduced IGF-1 signaling does not extend lifespan in mitochondrial mutator mice, according to a recent study that explores the interplay b...
Read more →Applying Mendelian Randomization to the Correlation Between Fitness and Health
A recent study employing Mendelian randomization has provided compelling evidence for the causal role of genetically predicted aerobic fi...
Read more →Common IBS medications linked to higher risk of death in major study
A comprehensive study led by researchers at Cedars-Sinai Health Sciences University has uncovered significant long-term risks associated ...
Read more →Mayo Clinic and Sana partner to advance Type 1 diabetes cell therapy
Sana Biotechnology has entered a strategic collaboration with Mayo Clinic to advance SC451, an investigational hypoimmune-modified pancre...
Read more →Mesoblast expands into CAR platform acquisition
Mesoblast has secured an exclusive worldwide license for a patented chimeric antigen receptor (CAR) technology platform, aimed at enhanci...
Read more →Hone Health integrates BodySpec DEXA scans into longevity OS
Hone Health has partnered with BodySpec to enhance its personalized operating system for longevity by integrating clinical-grade DEXA bod...
Read more →How low should blood pressure go? Science has the answer
New research from Mass General Brigham indicates that targeting a systolic blood pressure below 120 mm Hg may significantly enhance cardi...
Read more →This cheap drug could help people with type 1 diabetes use less insulin
A recent clinical trial led by the Garvan Institute of Medical Research has revealed that metformin, a century-old drug primarily used fo...
Read more →April 15, 2026
Does Tau Aggregation Spread from Region to Region in the Aging Brain?
A recent study investigates the spatiotemporal dynamics of tau aggregation in the aging brain, focusing on whether tau proteins spread fr...
Read more →Technogym and Google Cloud expand AI fitness
Technogym has entered a multi-year collaboration with Google Cloud to integrate generative AI into its fitness ecosystem, marking a signi...
Read more →Hong Kong to host APAC longevity summit 2026
The 2026 Asia-Pacific Healthy Longevity International Summit (APAC-LMIS), set to take place in Hong Kong from October 1-4, will gather ar...
Read more →Lecanemab’s next phase: real-world treatment
Eisai is making significant strides in the treatment of early Alzheimer’s disease with the presentation of new data on lecanemab at the 2...
Read more →Workers rethink benefits: healthspan comes first
A recent analysis by MyHealthPal reveals a significant shift in employee priorities, with 60% of workers now valuing private health insur...
Read more →Vitamin C Alleviates Aging in Cynomolgus Monkeys
Vitamin C has been identified as a potent inhibitor of the lipid metabolism enzyme **ACSL4, which plays a crucial role in the process ter...
Read more →Australia’s Kazia pays research institute $1.4M for epigenetic platform, preclinical drug
Kazia Therapeutics has entered into a strategic partnership with QIMR Berghofer, committing $1.4 million upfront to access an innovative ...
Read more →Astrocyte-based CAR immunotherapy against Alzheimer’s disease
Marco Colonna and his team have made significant strides in developing a novel approach to Alzheimer’s disease through engineered astrocy...
Read more →Anavex highlights shared autophagy biology in autism and Alzheimer’s
Anavex Life Sciences has unveiled compelling findings that establish a connection between autism spectrum disorder (ASD) and Alzheimer’s ...
Read more →Cellular Senescence and Mitochondrial Dysfunction and the Aging of the Vascular Endothelium
**Researchers have reviewed the interplay between cellular senescence and mitochondrial dysfunction in the aging of the vascular endothel...
Read more →Homoharringtonine as a Senotherapeutic Drug
**Homoharringtonine (HHT), an FDA-approved anti-leukemic drug, has emerged as a promising candidate for senotherapeutic applications, dem...
Read more →Scientists discover gene that helps the brain repair itself
Researchers have identified a genetic mutation in the Retsat gene that enables high-altitude animals such as yaks and Tibetan antelopes t...
Read more →AI identifies early risk patterns for skin cancer
A recent study from the University of Gothenburg demonstrates that artificial intelligence (AI) can effectively identify individuals at e...
Read more →International patent published for sirtuin 6 muscle therapy
Genflow Biosciences Plc has unveiled its Patent Cooperation Treaty application WO 2026/062177 A1, which details innovative variants of si...
Read more →Doing this throughout life may cut Alzheimer’s risk by 38%
A recent study published in Neurology by researchers at Rush University Medical Center reveals that lifelong cognitive enrichment—through...
Read more →Remission Medical closes Series A to expand virtual rheumatology
Remission Medical has successfully closed a Series A funding round led by Blue Heron Capital, aimed at expanding its virtual rheumatology...
Read more →RNA therapies research lists 80+ companies, 100+ drugs
A comprehensive analysis from ResearchAndMarkets.com has unveiled an extensive overview of the RNA therapeutics landscape, profiling over...
Read more →95% of people carry this virus and scientists may have just found how to stop it
Researchers at Fred Hutchinson Cancer Center have made significant strides in combating Epstein-Barr virus (EBV), a virus that infects ap...
Read more →This common gout drug may slash heart attack and stroke risk
A large-scale study led by researchers at the University of Nottingham has revealed that urate-lowering medications, particularly allopur...
Read more →Mapping the landscape of geriatric medicine education, training and practice in Europe
**Geriatric Medicine (GM) has been recognized as a distinct specialty in 24 out of 38 surveyed European countries, with specialty trainin...
Read more →Imaging interface-controlled bulk oxygen spillover
**Recent findings from a team led by researchers at the Dalian Institute of Chemical Physics reveal a novel mechanism of oxygen spillover...
Read more →